Benzinga's Top Pre-Market Gainers
BG Medicine (NASDAQ: BGMD) soared 11.54% to $3.77 in the pre-market trading. BG Medicine obtained a CE Mark enabling the commercial sale of the CardioSCORE(TM) test in the EU.
Sucampo Pharmaceuticals (NASDAQ: SCMP) moved up 10.66% to $5.50 in the pre-market session. Sucampo Pharma received approval of an sNDA for RESCULA (unoprostone isopropyl ophthalmic solution) from the FDA.
Oncothyreon (NASDAQ: ONTY) surged 4.58% to $4.80 in the pre-market session. Oncothyreon's trailing-twelve-month ROE is -33.87%.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.